<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font19">fever </span>
   <span class="font17">yellow </span>
   <span class="font15">YFV </span>
   <span class="font15">that </span>
   <span class="font15">with </span>
   <span class="font15">[]. </span>
   <span class="font15">for </span>
   <span class="font14">vaccination </span>
   <span class="font14">vaccine </span>
   <span class="font12">{background </span>
   <span class="font12">from </span>
   <span class="font12">are </span>
   <span class="font12">virus </span>
   <span class="font12">against </span>
   <span class="font12">have </span>
   <span class="font12">margin </span>
   <span class="font12">immunity </span>
   <span class="font12">{border-style </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">The </span>
   <span class="font11">cases </span>
   <span class="font11">was </span>
   <span class="font11">Infect </span>
   <span class="font11">outbreaks </span>
   <span class="font11">been </span>
   <span class="font11">regions </span>
   <span class="font11">Trop </span>
   <span class="font11">global </span>
   <span class="font11">has </span>
   <span class="font11">protection </span>
   <span class="font11">vaccines </span>
   <span class="font11">disease </span>
   <span class="font11">outbreak </span>
   <span class="font11">years </span>
   <span class="font11">Africa </span>
   <span class="font11">[], </span>
   <span class="font11">epidemic </span>
   <span class="font11">not </span>
   <span class="font11">transmission </span>
   <span class="font11">South </span>
   <span class="font11">between </span>
   <span class="font11">dose </span>
   <span class="font11">had </span>
   <span class="font11">infection </span>
   <span class="font11">rates </span>
   <span class="font11">studies </span>
   <span class="font11">Asia </span>
   <span class="font11">However, </span>
   <span class="font11">Med </span>
   <span class="font11">YFD </span>
   <span class="font11">during </span>
   <span class="font11">endemic </span>
   <span class="font11">non-endemic </span>
   <span class="font11">safety </span>
   <span class="font10">Angola </span>
   <span class="font10">Yellow </span>
   <span class="font10">after </span>
   <span class="font10">antibody </span>
   <span class="font10">booster </span>
   <span class="font10">cell </span>
   <span class="font10">coverage </span>
   <span class="font10">fractional </span>
   <span class="font10">immunization </span>
   <span class="font10">into </span>
   <span class="font10">low </span>
   <span class="font10">mosquito </span>
   <span class="font10">new </span>
   <span class="font10">patients </span>
   <span class="font10">seroconversion </span>
   <span class="font10">use </span>
   <span class="font10">were </span>
   <span class="font10">Dise./journal.pntd. </span>
   <span class="font10">Negl </span>
   <span class="font10">Therefore, </span>
   <span class="font10">clinical </span>
   <span class="font10">countries </span>
   <span class="font10">development </span>
   <span class="font10">high </span>
   <span class="font10">mass </span>
   <span class="font10">more </span>
   <span class="font10">neutralizing </span>
   <span class="font10">px; </span>
   <span class="font10">responses </span>
   <span class="font10">severe </span>
   <span class="font10">than </span>
   <span class="font10">which </span>
   <span class="font10">{font-family </span>
   <span class="font10">Brazil </span>
   <span class="font10">Health </span>
   <span class="font10">This </span>
   <span class="font10">both </span>
   <span class="font10">campaigns </span>
   <span class="font10">control </span>
   <span class="font10">dosing </span>
   <span class="font10">font-size </span>
   <span class="font10">immune </span>
   <span class="font10">over </span>
   <span class="font10">risk </span>
   <span class="font10">spread </span>
   <span class="font10">where </span>
   <span class="font10">Organization </span>
   <span class="font10">WHO </span>
   <span class="font10">World </span>
   <span class="font10">also </span>
   <span class="font10">antibodies </span>
   <span class="font10">associated </span>
   <span class="font10">currently </span>
   <span class="font10">different </span>
   <span class="font10">double; </span>
   <span class="font10">due </span>
   <span class="font10">high-risk </span>
   <span class="font10">host </span>
   <span class="font10">human </span>
   <span class="font10">increased </span>
   <span class="font10">infections </span>
   <span class="font10">large </span>
   <span class="font10">mortality </span>
   <span class="font10">most </span>
   <span class="font10">previously </span>
   <span class="font10">rapidly </span>
   <span class="font10">reported </span>
   <span class="font10">response </span>
   <span class="font10">single </span>
   <span class="font10">strategy </span>
   <span class="font10">these </span>
   <span class="font10">this </span>
   <span class="font10">treatment </span>
   <span class="font10">used </span>
   <span class="font10">vaccine: </span>
   <span class="font10">viral </span>
   <span class="font10">(i.e., </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">Galidesivir </span>
   <span class="font10">NHP </span>
   <span class="font10">West </span>
   <span class="font10">YFI </span>
   <span class="font10">adverse </span>
   <span class="font10">age </span>
   <span class="font10">al.Yellow </span>
   <span class="font10">any </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">can </span>
   <span class="font10">challenge </span>
   <span class="font10">children </span>
   <span class="font10">cycle </span>
   <span class="font10">doses </span>
   <span class="font10">elimination </span>
   <span class="font10">epidemiology </span>
   <span class="font10">events </span>
   <span class="font10">following </span>
   <span class="font10">future </span>
   <span class="font10">highly </span>
   <span class="font10">humans </span>
   <span class="font10">initiative </span>
   <span class="font10">limited </span>
   <span class="font10">major </span>
   <span class="font10">post-vaccination </span>
   <span class="font10">protective </span>
   <span class="font10">re-emergence </span>
   <span class="font10">remains </span>
   <span class="font10">sero-protection </span>
   <span class="font10">significantly </span>
   <span class="font10">solid; </span>
   <span class="font10">there </span>
   <span class="font10">two </span>
   <span class="font10">urban </span>
   <span class="font10">waning </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Aedes </span>
   <span class="font10">African </span>
   <span class="font10">America </span>
   <span class="font10">Brazil: </span>
   <span class="font10">Brazilian </span>
   <span class="font10">Fever </span>
   <span class="font10">PRNT </span>
   <span class="font10">Republic </span>
   <span class="font10">Sofosbuvir </span>
   <span class="font10">While </span>
   <span class="font10">among </span>
   <span class="font10">analysis </span>
   <span class="font10">animal </span>
   <span class="font10">antivirals </span>
   <span class="font10">article </span>
   <span class="font10">attenuated </span>
   <span class="font10">bold </span>
   <span class="font10">burden </span>
   <span class="font10">but </span>
   <span class="font10">case </span>
   <span class="font10">changing </span>
   <span class="font10">confirmed </span>
   <span class="font10">could </span>
   <span class="font10">courier; </span>
   <span class="font10">em; </span>
   <span class="font10">evidence </span>
   <span class="font10">flavivirus </span>
   <span class="font10">flaviviruses </span>
   <span class="font10">greater </span>
   <span class="font10">health </span>
   <span class="font10">highlighted </span>
   <span class="font10">humans, </span>
   <span class="font10">induces </span>
   <span class="font10">infectious </span>
   <span class="font10">influence </span>
   <span class="font10">lack </span>
   <span class="font10">led </span>
   <span class="font10">live </span>
   <span class="font10">low-risk </span>
   <span class="font10">molecular </span>
   <span class="font10">need </span>
   <span class="font10">non-human </span>
   <span class="font10">observed </span>
   <span class="font10">only </span>
   <span class="font10">our </span>
   <span class="font10">outbreaks. </span>
   <span class="font10">post </span>
   <span class="font10">potential </span>
   <span class="font10">prior </span>
   <span class="font10">production </span>
   <span class="font10">pt;} </span>
   <span class="font10">rapid </span>
   <span class="font10">reduced </span>
   <span class="font10">regions. </span>
   <span class="font10">required </span>
   <span class="font10">role </span>
   <span class="font10">several </span>
   <span class="font10">similar </span>
   <span class="font10">strain </span>
   <span class="font10">through </span>
   <span class="font10">time </span>
   <span class="font10">towards </span>
   <span class="font10">vaccinated </span>
   <span class="font10">vaccination. </span>
   <span class="font10">when </span>
   <span class="font10">widespread </span>
   <span class="font10">wildtype </span>
   <span class="font10">will </span>
   <span class="font10">within </span>
  </p>
 </body>
</html>
